References
- 1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017;135(10): e146–e60310.1161/CIR.000000000000049128264899
- 2. Baillieul S, Revol B, Jullian-Desayes I, Joyeux-Faure M, Tamisier R, Pépin J-L. Diagnosis and management of central sleep apnea syndrome. Expert Review of Respiratory Medicine. 2019;1–13. doi:10.1080/17476348.2019.1604226.10.1080/17476348.2019.160422631014146
- 3. Hetland A, Vistnes M, Haugaa KH, Liland KH, Olseng M, Edvardsen T. Obstructive sleep apnea versus central sleep apnea: prognosis in systolic heart failure. Cardiovascular Diagnosis and Therapy. 2020;10(3): 396–404. doi:10.21037/cdt.2020.03.02.10.21037/cdt.2020.03.02736927132695620
- 4. Kahwash R, Khayat RN. A practical approach to the identification and management of sleep-disordered breathing in heart failure patients. Sleep Medicine Clinics. 2017;12(2): 205–219. doi:10.1016/j.jsmc.2017.01.002.10.1016/j.jsmc.2017.01.00228477775
- 5. Randerath W, Deleanu O, Schiza S, Pepin J-L. Central sleep apnoea and periodic breathing in heart failure: prognostic significance and treatment options. European Respiratory Review. 2019;28(153): 190084. doi:10.1183/16000617.0084-2019.10.1183/16000617.0084-201931604817
- 6. American Academy of Sleep Medicine. International classification of sleep disorders, 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.
- 7. Kryger MH, Roth T, Dement WC. Principles and practice of sleep medicine, 6th ed. Elsevier; 2016. eBook ISBN: 9780323377522, Hardcover ISBN: 9780323242882, Imprint: Elsevier, Published Date: 29th December 2015.
- 8. Randerath W, Verbraecken J, Andreas S, Arzt M, Bloch KE, Brack T, et al. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. European Respiratory Journal. 2017;49(1): 1600959.10.1183/13993003.00959-201627920092
- 9. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. European Journal of Heart Failure. 2016;18(8): 891–975. doi:10.1002/ejhf.592.10.1002/ejhf.59227207191
- 10. Martins RT, Eckert DJ. Central sleep apnea due to other medical disorders. Sleep Medicine Clinics. 2014;9: 57–67.10.1016/j.jsmc.2013.10.002
- 11. Pinna GD, Robbi E, Pizza F, Taurino AE, Pronzato C, La Rovere MT, et al. Can cardiorespiratory polygraphy replace portable polysomnography in the assessment of sleep-disordered breathing in heart failure patients? Sleep Breath. 2014;18: 475–482.
- 12. Eckert DJ, Jordan AS, Merchia P, Malhotra A. Central sleep apnea: pathophysiology and treatment. Chest. 2007;131: 595–607.10.1378/chest.06.2287228719117296668
- 13. Spaak J, Egri ZJ, Kubo T, Yu E, Ando S-I, Kaneko Y, et al. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension. 2005;46:1327–1332.10.1161/01.HYP.0000193497.45200.6616286569
- 14. Arzt M, Harth M, Luchner A, Muders F, Holmer SR, Blumberg FC, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea. Circulation. 2003;107: 1998–2003.10.1161/01.CIR.0000065227.04025.C2
- 15. Jelic S, Le Jemtel TH. Sleep-disordered breathing in acute decompensated heart failure. Current Heart Failure Reports. 2009;6: 169–175.10.1007/s11897-009-0024-6
- 16. Corra U, Pistono M, Mezzani A, Braghiroli A, Giordano A, Lanfranchi P, et al. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation. 2006;113: 44–50.10.1161/CIRCULATIONAHA.105.543173
- 17. Naughton MT. Cheyne–Stokes respiration: friend or foe? Thorax. 2012;67: 357–360.
- 18. Emdin M, Passino C, Giannoni A. After the SERVE-HF trial, is there still a need for treatment of central apnea? Journal of CardiacFailure. 2015;21: 903–905.
- 19. Cowie MR, Woehrle H, Wegscheider K, Angermann C, d’ Ortho MP, Erdmann E, et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. The New England Journal of Medicine. 2015;373(12): 1095–1105.10.1056/NEJMoa1506459
- 20. Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. Journal of the American College of Cardiology. 2007;49: 2028–2034.10.1016/j.jacc.2007.01.084
- 21. Oldenburg O, Wellmann B, Buchholz A, Bitter T, Fox H, Thiem U, et al. Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients. European Heart Journal. 2016;37: 1695–1703.10.1093/eurheartj/ehv624
- 22. Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. The Lancet RespiratoryMedicine. 2015;3:310–318.10.1016/S2213-2600(15)00043-0
- 23. Yumino D, Wang H, Floras JS, Newton GE, Mak S, Ruttanaumpawan P, et al. Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. Journal of Cardiac Failure. 2009;15: 279–285.10.1016/j.cardfail.2008.11.01519398074
- 24. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. American Journal of Respiratory and Critical Care Medicine. 1999;160: 1101–1106.10.1164/ajrccm.160.4.990302010508793
- 25. Khayat R, Jarjoura D, Porter K, Sow A, Wannemacher J, Dohar R, et al. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. European Heart Journal. 2015;36: 1463–1469.10.1093/eurheartj/ehu522446563525636743
- 26. Tremel F, Pepin JL, Veale D, Wuyam B, Siché JP, Mallion JM, et al. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. European Heart Journal. 1999;20: 1201–1209.10.1053/euhj.1999.154610448029
- 27. Oldenburg O, Bitter T, Fox H, et al. Heart failure. Somnology. 2014;18: 19–25.10.1007/s11818-013-0652-7
- 28. Kreuz J, Skowasch D, Horlbeck F, Atzinger C, Schrickel JW, Lorenzen H, et al. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death. The American Journal of Cardiology. 2013;111: 1319–1323.10.1016/j.amjcard.2013.01.27723411108
- 29. Arzt M, Woehrle H, Oldenburg O, Graml A, Suling A, Erdmann E, et al. Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF Registry. JACC Heart Failure. 2016;4: 116–125.10.1016/j.jchf.2015.09.01426682790
- 30. Arzt M, Oldenburg O, Graml A, Erdmann E, Teschler H, Wegscheider K, et al. Phenotyping of sleep-disordered breathing in patients with chronic heart failure with reduced ejection fraction – the SchlaHF registry. Journal of the AmericanHeart Association. 2017;6(12): e005899. doi:10.1161/JAHA.116.005899.10.1161/JAHA.116.005899577899429187390
- 31. Naughton MT, Kee K. Sleep apnoea in heart failure: to treat or not to treat? Respirology. 2017;22: 217–229.
- 32. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr., Colvin MM, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Journal of Cardiac Failure. 2017;23(8): 628–651.10.1016/j.cardfail.2017.04.01428461259
- 33. Gwag HB, Park Y, Lee SS, Kim JS, Park K-M, On YK, et al. Rationale, design, and endpoints of the ‘DEvice-Detected CArdiac Tachyarrhythmic Events and Sleep-disordered Breathing (DED-iCATES)’ study: prospective multicenter observational study of device-detected tachyarrhythmia and sleep-disordered breathing. International Journal of Cardiology. 2019;280: 69–73.10.1016/j.ijcard.2019.01.04530665804
- 34. Khayat RN, Jarjoura D, Patt B, Yamokoski T, Abraham WT. In-hospital testing for sleep-disordered breathing in hospitalized patients with decompensated heart failure: report of prevalence and patient characteristics. Journal of Cardiac Failure. 2009;15(9): 739–746.10.1016/j.cardfail.2009.05.005277283019879459
- 35. Khayat R, Abraham W, Patt B, Brinkman V, Wannemacher J, Porter K, et al. Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. Journal of Cardiac Failure. 2012;18: 534–540.10.1016/j.cardfail.2012.05.003348261222748486
- 36. Quintana-Gallego E, Villa-Gil M, Carmona-Bernal C, Botebol-Benhamou G, Martínez-Martínez A, Sánchez-Armengol A, et al. Home respiratory polygraphy for diagnosis of sleep- disordered breathing in heart failure. European Respiratory Journal. 2004;24: 443–448.10.1183/09031936.04.0014060315358704
- 37. Akira T, Yoshiyuki K, Shigeru N, Munenori K, Kadota J-I. Relationship between -Blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest. 2007;131(1): 130–135.10.1378/chest.06-091917218566
- 38. Walsh JT, Andrews R, Starling R, Cowley AJ, Johnston IDA, Kinnear WJ. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. British Heart Journal. 1995;73: 237–241.10.1136/hrt.73.3.2374838057727183
- 39. Perger E, Jutant E-M, Redolfi S. Targeting volume overload and overnight rostral fluid shift: a new perspective to treat sleep apnea. Sleep Medicine Reviews. 2018;42: 160–170. doi:10.1016/j. smrv.2018.07.008
- 40. Shigemitsu M, Nishio K, Kusuyama T, Itoh S, Konno N, Katagiri T. Nocturnal oxygen therapy prevents progress of congestive heart failure with central sleep apnea. International Journal of Cardiology. 2007;115(3): 354–360.10.1016/j.ijcard.2006.03.01816806535
- 41. Schwarz EI, Scherff F, Haile SR, Steier J, Kohler M. Effect of treatment of central sleep apnea/Cheyne–Stokes respiration on left ventricular ejection fraction in heart failure: a network meta-analysis. Journal of Clinical Sleep Medicine. 2019;15(12): 1817–1825. doi:10.5664/jcsm.8092.10.5664/jcsm.8092709919331855167
- 42. Nakao YM, Ueshima K, Yasuno S, Sasayama S. Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study. Heart Vessels. 2016;31(2): 165–172.10.1007/s00380-014-0592-625348726
- 43. Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation. 2007;115(25): 3173–3180.10.1161/CIRCULATIONAHA.106.68348217562959
- 44. Ryan CM Usui K, Floras JS, et al., Effect of CPAP on ventricular ectopy in heart failure patients with OSA. Thorax 2005;60: 781–785.10.1136/thx.2005.040972174752015994252
- 45. Antic NA, Catcheside P, Buchan C, Hensley M, Naughton MT, Rowland S, et al. The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep. 2011;34(1): 111–119.10.1093/sleep/34.1.111300178921203366
- 46. Wimms A, Ketheeswaran S, Ziegenbein C, Jennings L, Woehrle H. Impact of a new nasal pillows mask on patients’ acceptance, compliance, and willingness to remain on CPAP therapy. Sleep Disorder. 2016;2016: 6713236. doi:10.1155/2016/6713236.10.1155/2016/6713236501498027648308
- 47. Voigt J, Emani S, Gupta S, Germany R, Khayat R. Meta- analysis comparing outcomes of therapies for patients with central sleep apnea and heart failure with reduced ejection fraction. The American Journal of Cardiology, 2020;127: 73–83. doi:10.1016/j.amj-card.2020.04.011.
- 48. Kazimierczak A, Krzyżanowski K, Wierzbowski R, Ryczek R, Smurzyński P, Michałkiewicz D, et al. Resolution of exercise oscillatory ventilation with adaptive servoventilation in patients with chronic heart failure and Cheyne–Stokes respiration: preliminary study. Kardiologia Polska. 2011;69(12): 1266–1271.
- 49. Javaheri S, Brown LK, Randerath WJ. Positive airway pressure therapy with adaptive servoventilation part 1: operational algorithms. Chest. 2014;146(2): 514–523.10.1378/chest.13-177625091757
- 50. Malfertheiner MV, Lerzer C, Kolb L, Heider K, Zeman F, Gfüllner F, et al. Whom are we treating with adaptive servo-ventilation? A clinical post hoc analysis. Clinical Research in Cardiology. 2017;106(9): 702–710. doi:10.1007/s00392-017- 11123.
- 51. Philippe C, Stoica-Herman M, Drouot X, Raffestin B, Escourrou P, Hittinger L, et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne–Stokes respiration in heart failure over a six month period. Heart. 2006;92(3): 337–342. doi: 10.1136/hrt.2005.060038.10.1136/hrt.2005.060038186083615964943
- 52. Kasai T, Usui Y, Yoshioka T, Yanagisawa N, Takata Y, Narui K, et al. Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne–Stokes respiration. Circulation: Heart Failure. 2010;3(1): 140–148. doi:10.1161/CIRCHEARTFAILURE.109.868786.10.1161/CIRCHEARTFAILURE.109.86878619933407
- 53. Hetzenecker A, Escourrou P, Kuna ST, Series F, Lewis K, Birner C, et al. Treatment of sleep apnea in chronic heart failure patients with auto-servo ventilation improves sleep fragmentation: a randomized controlled trial. Sleep Medicine. 2016;17: 25–31. doi: 10.1016/j.sleep.2015.08.020.10.1016/j.sleep.2015.08.02026847970
- 54. Hetzenecker A, Roth T, Birner C, Maier LS, Pfeifer M, Arzt M. Adaptive servo-ventilation therapy of central sleep apnoea and its effect on sleep quality. Clinical Research in Cardiology. 2016;105(3): 189–195. doi: 10.1007/s00392-015-0904-6.10.1007/s00392-015-0904-626342603
- 55. D’Elia E, Vanoli E, La Rovere MT, Fanfulla F, Maggioni A, Casali V, et al. Adaptive servo ventilation reduces central sleep apnea in chronic heart failure patients: beneficial effects on autonomic modulation of heart rate. Journal of Cardiovascular Medicine (Hagerstown). 2013;14: 296–300.10.2459/JCM.0b013e32835364b222498996
- 56. Oldenburg O, Schmidt A, Lamp B, Bitter T, Muntean BG, Langer C, et al. Adaptive servoventilation improves cardiac function in patients with chronic heart failure and Cheyne–Stokes respiration. European Journal of Heart Failure. 2008;10: 581–586.10.1016/j.ejheart.2008.04.00718486550
- 57. Nakamoto T. Sleep-disordered breathing – a real therapeutic target for hypertension, pulmonary hypertension, ischemic heart disease, and chronic heart failure? Journal of Nippon Medical School. 2018;85(2): 70–77. doi:10.1272/jnms.2018_85-12.10.1272/jnms.2018_85-1229731500
- 58. Schwarz EI, Kohler M. Randomized controlled trials on the comparative effect of treatment modalities of central sleep apnea with Cheyne–Stokes respiration on cardiovascular outcomes and physiology studies required. Journal of Clinical Sleep Medicine. 2020;16(4): 653–654.10.5664/jcsm.8306716144032022677
- 59. Kolb L, Arzt M, Stadler S. et al. Adaptive servo-ventilation in patients with chronic heart failure and sleep disordered breathing: predictors of usage. Sleep & Breathing. 2020. doi:10.1007/s11325-020-02182-2. [Online ahead of print].10.1007/s11325-020-02182-2819588532880808
- 60. McSharry DG, Eckert DJ, Malhotra A. European Respiratory Monograph. 2010;50: 381–395.
- 61. Noda A, Izawa H, Asano H, Nakata S, Hirashiki A, Murase Y, et al. Beneficial effect of bilevel positive airway pressure on left ventricular function in ambulatory patients with idiopathic dilated cardiomyopathy and central sleep apnea–hypopnea: a preliminary study. Chest. 2007;131(6): 1694–1701.10.1378/chest.06-227117400681
- 62. Lorenzi-Filho G, Rankin F, Bies I, Douglas Bradley T. Effects of inhaled carbon dioxide and oxygen on Cheyne–Stokes respiration in patients with heart failure. American Journal of Respiratory and Critical Care Medicine. 1999;159(5 Pt 1): 1490–1498.10.1164/ajrccm.159.5.981004010228116
- 63. Xie A, Skatrud JB, Puleo DS, Rahko PS, Dempsey JA. Apnea-hypopnea threshold for CO2 in patients with congestive heart failure. American Journal of Respiratory and Critical Care Medicine. 2002;165(9): 1245–1250.10.1164/rccm.200110-022OC11991873
- 64. Murtaza G, Turagam MK, Akella K, Madoukh B, Sharma SP, Gopinathannair R, et al. Pacing therapies for sleep apnea and cardiovascular outcomes: a systematic review. Journal of Interventional Cardiac Electrophysiology. 2020. doi:10.1007/s10840-020-00760-8. [Online ahead of print].10.1007/s10840-020-00760-832445012
- 65. Mansfield DR, Solin P, Roebuck T, Bergin P, Kaye DM, Naughton MT. The effect of successful heart transplant treatment of heart failure on central sleep apnea. Chest. 2003;124: 1675–1681.10.1378/chest.124.5.167514605034